# Fold Holdings, Inc.: financial statements, quarterly

FLD · Nasdaq · CIK 1889123 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fld.md) · [Financials](/companies/fld/financials.md) · [Filings](/companies/fld/filings.md) · [Insiders](/companies/fld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fld/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [4.9](/filings/0000950170-25-072818.md) | [5.1](/filings/0000950170-25-107335.md) | [5.2](/filings/0001193125-25-274317.md) | [8.4 d](/filings/0001193125-26-110808.md) | [7.1](/filings/0001193125-26-219476.md) | [8.2](/filings/0001193125-26-344668.md) | [7.4](/filings/0001193125-25-274317.md) | [9.1 d](/filings/0001193125-26-110808.md) | [5.6](/filings/0001193125-26-219476.md) | [6.1](/filings/0001193125-26-344668.md) |
| Operating income | $m | [(0.7)](/filings/0001213900-24-096828.md) | [(1.5) d](/filings/0001013762-25-004107.md) | [(0.7)](/filings/0001213900-24-043035.md) | [(0.6)](/filings/0001213900-24-067164.md) | [(0.8)](/filings/0001213900-24-096828.md) | [(0.8) d](/filings/0001013762-25-004107.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | [0.0](/filings/0000950170-25-072818.md) | [0.0](/filings/0000950170-25-107335.md) | [0.0](/filings/0001193125-25-274317.md) | [0.2 d](/filings/0001193125-26-110808.md) | [1.3](/filings/0001193125-26-219476.md) | [2.0](/filings/0001193125-26-344668.md) | [1.2](/filings/0001193125-25-274317.md) | [1.3 d](/filings/0001193125-26-110808.md) | [2.3](/filings/0001193125-26-219476.md) | [0.9](/filings/0001193125-26-344668.md) |
| Income tax | $m | [0.7](/filings/0001213900-24-096828.md) | [0.5 d](/filings/0001013762-25-004107.md) | [0.0](/filings/0000950170-25-072818.md) | [(0.0)](/filings/0000950170-25-107335.md) | [0.0](/filings/0001193125-25-274317.md) | [(0.0) d](/filings/0001193125-26-110808.md) | [0.0](/filings/0001193125-26-219476.md) | [0.0](/filings/0001193125-26-344668.md) | [(0.0)](/filings/0001193125-25-274317.md) | [(0.0) d](/filings/0001193125-26-110808.md) | [0.0](/filings/0001193125-26-219476.md) | [0.0](/filings/0001193125-26-344668.md) |
| Net income | $m | [1.2](/filings/0001213900-24-096828.md) | [0.2 d](/filings/0001013762-25-004107.md) | [(0.9)](/filings/0000950170-25-072818.md) | [(2.3)](/filings/0000950170-25-107335.md) | [(62.3)](/filings/0001193125-25-274317.md) | [0.5 d](/filings/0001193125-26-110808.md) | [(48.9)](/filings/0001193125-26-219476.md) | [13.4](/filings/0001193125-26-344668.md) | [0.6](/filings/0001193125-25-274317.md) | [(34.7) d](/filings/0001193125-26-110808.md) | [(29.2)](/filings/0001193125-26-219476.md) | [(9.7)](/filings/0001193125-26-344668.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.16)](/filings/0000950170-25-072818.md) | [(0.40)](/filings/0000950170-25-107335.md) | [(10.68)](/filings/0001193125-25-274317.md) | not reported | [(1.92)](/filings/0001193125-26-219476.md) | [0.28](/filings/0001193125-26-344668.md) | [0.01](/filings/0001193125-25-274317.md) | not reported | [(0.59)](/filings/0001193125-26-219476.md) | [(0.19)](/filings/0001193125-26-344668.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.16)](/filings/0000950170-25-072818.md) | [(0.40)](/filings/0000950170-25-107335.md) | [(10.68)](/filings/0001193125-25-274317.md) | not reported | [(1.92)](/filings/0001193125-26-219476.md) | [0.29](/filings/0001193125-26-344668.md) | [0.01](/filings/0001193125-25-274317.md) | not reported | [(0.59)](/filings/0001193125-26-219476.md) | [(0.19)](/filings/0001193125-26-344668.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001213900-23-086172.md) | [0.0](/filings/0001213900-24-096828.md) | [0.1](/filings/0001213900-24-043035.md) | [0.1](/filings/0001213900-24-067164.md) | [0.0](/filings/0001213900-24-096828.md) | [18.3](/filings/0001193125-26-110808.md) | [11.7](/filings/0000950170-25-072818.md) | [6.6](/filings/0000950170-25-107335.md) | [6.7](/filings/0001193125-25-274317.md) | [7.7](/filings/0001193125-26-344668.md) | [11.5](/filings/0001193125-26-219476.md) | [28.4](/filings/0001193125-26-344668.md) |
| Current assets | $m | [0.1](/filings/0001213900-23-086172.md) | [0.3](/filings/0001013762-25-004107.md) | [0.4](/filings/0001213900-24-043035.md) | [0.3](/filings/0001213900-24-067164.md) | [0.2](/filings/0001213900-24-096828.md) | [28.3](/filings/0001193125-26-110808.md) | [24.4](/filings/0000950170-25-072818.md) | [20.7](/filings/0000950170-25-107335.md) | [19.1](/filings/0001193125-25-274317.md) | [18.1](/filings/0001193125-26-344668.md) | [20.0](/filings/0001193125-26-219476.md) | [39.0](/filings/0001193125-26-344668.md) |
| Total assets | $m | [165](/filings/0001213900-23-086172.md) | [166](/filings/0001013762-25-004107.md) | [51.5](/filings/0001213900-24-043035.md) | [51.8](/filings/0001213900-24-067164.md) | [52.2](/filings/0001213900-24-096828.md) | [126](/filings/0001193125-26-110808.md) | [149](/filings/0000950170-25-072818.md) | [182](/filings/0000950170-25-107335.md) | [191](/filings/0001193125-25-274317.md) | [153](/filings/0001193125-26-344668.md) | [78.3](/filings/0001193125-26-219476.md) | [52.5](/filings/0001193125-26-344668.md) |
| Current liabilities | $m | [2.9](/filings/0001213900-23-086172.md) | [3.4](/filings/0001013762-25-004107.md) | [5.3](/filings/0001213900-24-043035.md) | [5.6](/filings/0001213900-24-067164.md) | [6.4](/filings/0001213900-24-096828.md) | [21.9](/filings/0001193125-26-110808.md) | [11.1](/filings/0000950170-25-072818.md) | [12.9](/filings/0000950170-25-107335.md) | [13.0](/filings/0001193125-25-274317.md) | [21.1](/filings/0001193125-26-344668.md) | [42.0](/filings/0001193125-26-219476.md) | [21.2](/filings/0001193125-26-344668.md) |
| Total liabilities | $m | [12.8](/filings/0001213900-23-086172.md) | [4.5](/filings/0001013762-25-004107.md) | [6.5](/filings/0001213900-24-043035.md) | [6.8](/filings/0001213900-24-067164.md) | [7.6](/filings/0001213900-24-096828.md) | [193](/filings/0001193125-26-110808.md) | [76.7](/filings/0000950170-25-072818.md) | [93.6](/filings/0000950170-25-107335.md) | [96.3](/filings/0001193125-25-274317.md) | [90.5](/filings/0001193125-26-344668.md) | [42.0](/filings/0001193125-26-219476.md) | [21.2](/filings/0001193125-26-344668.md) |
| Shareholders' equity | $m | [(11.5)](/filings/0001213900-24-096828.md) | [(8.4)](/filings/0001193125-26-110808.md) | [(9.4)](/filings/0000950170-25-072818.md) | [(74.0)](/filings/0001193125-25-274317.md) | [(7.4)](/filings/0001213900-24-096828.md) | [(67.8)](/filings/0001193125-26-344668.md) | [71.9](/filings/0001193125-26-219476.md) | [88.5](/filings/0001193125-26-344668.md) | [94.7](/filings/0001193125-25-274317.md) | [63.0](/filings/0001193125-26-344668.md) | [36.4](/filings/0001193125-26-219476.md) | [31.3](/filings/0001193125-26-344668.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.1) d](/filings/0001213900-24-096828.md) | [(1.0) d](/filings/0001013762-25-004107.md) | [(0.4)](/filings/0000950170-25-072818.md) | [(0.9) d](/filings/0000950170-25-107335.md) | [(2.2) d](/filings/0001193125-25-274317.md) | [0.1 d](/filings/0001193125-26-110808.md) | [(5.0)](/filings/0001193125-26-219476.md) | [(4.0) d](/filings/0001193125-26-344668.md) | [(2.5) d](/filings/0001193125-25-274317.md) | [(4.7) d](/filings/0001193125-26-110808.md) | [(6.6)](/filings/0001193125-26-219476.md) | [(9.5) d](/filings/0001193125-26-344668.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001013762-25-004107.md) | [115](/filings/0001213900-24-043035.md) | [0.0 d](/filings/0001213900-24-067164.md) | [0.0 d](/filings/0001213900-24-096828.md) | [1.2 d](/filings/0001013762-25-004107.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.8](/filings/0000950170-25-072818.md) | [5.8](/filings/0000950170-25-107335.md) | [5.8](/filings/0001193125-25-274317.md) | [25.4](/filings/0001193125-26-219476.md) | [47.6](/filings/0001193125-26-344668.md) | [46.9](/filings/0001193125-25-274317.md) | [49.7](/filings/0001193125-26-219476.md) | [51.8](/filings/0001193125-26-344668.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 55,077,187 at 2026-08-09, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-344668.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.